{
    "clinical_study": {
        "@rank": "48717", 
        "acronym": "BOOM3", 
        "arm_group": [
            {
                "arm_group_label": "omega-3 fatty acids", 
                "arm_group_type": "Experimental", 
                "description": "3 capsules each day during 8 weeks"
            }, 
            {
                "arm_group_label": "placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "3 capsules each day during 8 weeks"
            }
        ], 
        "brief_summary": {
            "textblock": "The main objective is to evaluate the effects of omega-3 fatty acids on hot flashes\n      frequency."
        }, 
        "brief_title": "Hot Flashes and Omega 3", 
        "completion_date": {
            "#text": "June 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Hot Flashes", 
            "Fatty Acids", 
            "Menopause"
        ], 
        "condition_browse": {
            "mesh_term": "Hot Flashes"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  menopause or peri menopause\n\n          -  complaining of hot flashes\n\n          -  social security affiliation\n\n          -  informed consent form signed\n\n        Exclusion Criteria:\n\n          -  primary pathology which can lead to hot flashes\n\n          -  allergy to omega-3 fatty acids\n\n          -  allergy to sea products\n\n          -  High consumption of fat fish or produced by the sea\n\n          -  iatrogenic hot flashes\n\n          -  actual omega-3 fatty acids consumption or in the 3 last months.\n\n          -  consumption of drug or other products for hot flashes in the last month\n\n          -  protected persons (L1121-5 to L1121-8 of French Public health code)"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "35 Years"
        }, 
        "enrollment": {
            "#text": "136", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 12, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02062528", 
            "org_study_id": "DCIC 13 15"
        }, 
        "intervention": [
            {
                "arm_group_label": "omega-3 fatty acids", 
                "description": "highly dosed in EPA", 
                "intervention_name": "omega-3 fatty acids", 
                "intervention_type": "Dietary Supplement", 
                "other_name": "groupe actif"
            }, 
            {
                "arm_group_label": "placebo", 
                "intervention_name": "placebo", 
                "intervention_type": "Dietary Supplement"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": "EPA", 
        "lastchanged_date": "February 12, 2014", 
        "location": {
            "contact": {
                "email": "AParis@chu-grenoble.fr", 
                "last_name": "PARIS Adeline", 
                "phone": "33476767383"
            }, 
            "facility": {
                "address": {
                    "city": "GRENOBLE cedex9", 
                    "country": "France", 
                    "zip": "38043"
                }, 
                "name": "Centre d'investigation clinique CIC1406"
            }, 
            "investigator": [
                {
                    "last_name": "Jean-Luc CRACOWSKI, MD-PhD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Claire CRACOWSKI, MD", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "2", 
        "official_title": "Evaluation de l'efficacit\u00e9 Des Acides Gras om\u00e9ga 3 Hautement concentr\u00e9s en EPA Sur Les bouff\u00e9es de Chaleur, Chez Des Femmes en p\u00e9riode de p\u00e9ri-m\u00e9nopause et m\u00e9nopause : \u00e9tude Monocentrique, en Groupes parall\u00e8les, contr\u00f4l\u00e9e, randomis\u00e9e vs Placebo", 
        "overall_contact": {
            "email": "AParis@chu-grenoble.fr", 
            "last_name": "Adeline PARIS, PharmD-PhD", 
            "phone": "04-76-76-73-83"
        }, 
        "overall_contact_backup": {
            "email": "BSPILUTTINI@vivatech.fr", 
            "last_name": "B\u00e9atrice SPILUTTINI, PhD"
        }, 
        "overall_official": {
            "affiliation": "Centre d'investigation clinique CIC1406", 
            "last_name": "Jean-Luc CRACOWSKI, MD-PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "France: ANSM - French Health Products Safety Agency", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "ANOVA by repeated measures", 
            "measure": "hot flashes frequency", 
            "safety_issue": "No", 
            "time_frame": "1 to 8 week"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02062528"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "difference betwwen week8 and week4 and week0", 
                "measure": "hot flashes frequency difference", 
                "safety_issue": "No", 
                "time_frame": "4 week and 8 week"
            }, 
            {
                "description": "ANOVA and difference", 
                "measure": "diurnal hot flashes", 
                "safety_issue": "No", 
                "time_frame": "week 1 to 8"
            }, 
            {
                "description": "ANOVA and difference", 
                "measure": "night hot flashes", 
                "safety_issue": "No", 
                "time_frame": "week 1 to 8"
            }, 
            {
                "description": "ANOVA and differences", 
                "measure": "vasomotors disorders", 
                "safety_issue": "No", 
                "time_frame": "week 1 to  week 8"
            }, 
            {
                "description": "sleep quality", 
                "measure": "Pittsburgh Sleep Quality Index (PSQI)", 
                "safety_issue": "No", 
                "time_frame": "week 0 and week 8"
            }, 
            {
                "description": "quality of life", 
                "measure": "HFRDIS", 
                "safety_issue": "No", 
                "time_frame": "week 0 and week 8"
            }, 
            {
                "description": "quality of life", 
                "measure": "The Menopause-Specific Quality of Life (MENQOL)", 
                "safety_issue": "No", 
                "time_frame": "week 0 and week 8"
            }, 
            {
                "measure": "Weight", 
                "safety_issue": "No", 
                "time_frame": "week 0 and week 8"
            }, 
            {
                "description": "fatty acids dosage", 
                "measure": "fatty acids dosage", 
                "safety_issue": "No", 
                "time_frame": "week 0 and week 8"
            }, 
            {
                "measure": "number of adverse events", 
                "safety_issue": "Yes", 
                "time_frame": "week 0 to week 8"
            }
        ], 
        "source": "Vivatech", 
        "sponsors": {
            "collaborator": {
                "agency": "Centre d'Investigation Clinique de Grenoble CIC1406", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Vivatech", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "March 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}